Therefore, the goal of treatment is to maintain serum PTH within the upper normal range, promoting calcium reabsorption in the kidneys and preventing hypercalciuria and the formation of renal stones, while minimizing adverse effects on bone mineralization [17]. The gene discussed is PTH; the disease is Hypercalciuria.